NCT04706481 Archival of Human Biological Samples in CU-Med Biobank
| NCT ID | NCT04706481 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2050-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-01-01 with a primary completion date of 2050-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.
Eligibility Criteria
Inclusion Criteria: * Enrolled subjects that have provided signed consent for the specimens and de-identified data to be collected, stored and distributed. Exclusion Criteria: * Subjects without signed informed consent for the specimens and de-identified data to be collected, stored and distributed.
Contact & Investigator
Ching Wan MA, MB BChir
STUDY CHAIR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT04706481 clinical trial?
This trial is open to participants of all sexes, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04706481 currently recruiting?
Yes, NCT04706481 is actively recruiting participants. Contact the research team at terryor@cuhk.edu.hk for enrollment information.
Where is the NCT04706481 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT04706481 clinical trial?
NCT04706481 is sponsored by Chinese University of Hong Kong. The principal investigator is Ching Wan MA, MB BChir at Chinese University of Hong Kong. The trial plans to enroll 10,000 participants.